Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027

NEW YORK, Sept. 4, 2017 /PRNewswire/ -- The top 50 generic drug producers had combined revenues of $92bn in 2016. The top 10 generic drug producers have 62% share of the total revenue made by these top 50 companies. 30% of the top 50 generic drug producers fall under the RoW region. This figure reflects the increasing penetration of generics on a global scale with many pharmaceutical companies realising this industry as a primary source of revenue.


Read the full report: http://www.reportlinker.com/p05089834/Pharma-Leader-Series-Top-Generic-Drug-Producers-Market-Forecast.html



How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 214-page report you will receive 74 tables and 71 figures – all unavailable elsewhere.

The 214-page report provides clear detailed insight into the top 50 generic drug producers. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

This report ranks the world's top 50 generic drug manufacturers according to their generic drug revenues in 2016.

Our report assesses the leading generic drug manufacturers worldwide. In general a company profile gives you the following information:
• Discussion of activities, technologies and recent financial results
• Assessment of developments - mergers and acquisitions (M&A), new products, outlooks, challenges and plans
• Historical revenue ($) and CAGR (%) of top players
• Forecasting of generic drug revenues to 2027 (for 18 leading companies).

This report discusses the factors that affect the industry:
• M&A activity and related partnerships
• Global and regional strategies - extending business reach
• Competition from companies based in emerging national markets
• Increasing specialisation by leading players, including big pharma companies
• Increasing consolidation of the generics industry
• Advances in production technologies, including difficult-to-make generics and biosimilars - important shifts and opportunities in the industry.

This report analyses the leading generic drug manufacturers in North America, including these companies:
• Mylan
• Pfizer
• Abbott
• Endo Pharmaceuticals
• Valeant

This report analyses the leading generic drug manufacturers in Europe, including these companies:
• Novartis (Sandoz)
• Sanofi
• Fresenius Kabi
• Pharmstandard
• Gedeon Richter
• Stada Arzneimittel.
• Perrigo

This report analyses the leading generic drug manufacturers in India, including these companies:
• Sun Pharmaceutical Industries
• Dr. Reddy's Laboratories
• Lupin
• Cipla
• Aurobindo
• Glenmark
• Torrent Pharma

This report analyses the leading generic drug manufacturers in RoW, including these companies:
• Teva Pharmaceutical Industries
• EMS
• Aspen Pharmacare
• Nichi-Iko
• Sawai Pharmaceutical
• Taro Pharmaceutical
Read the full report: http://www.reportlinker.com/p05089834/Pharma-Leader-Series-Top-Generic-Drug-Producers-Market-Forecast.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/pharma-leader-series-top-generic-drug-producers-market-forecast-2017-2027-300513563.html

SOURCE Reportlinker